title: [Current treatment strategies for Parkinson's disease].
authors.affiliation: Neurologische Klinik - Bewegungsstörungen und Neuromodulation, Medizinische Fakultät, UKD, Düsseldorf, Germany. martin.suedmeyer@uni-duesseldorf.de
authors.forename: M
authors.initials: M
authors.lastname: Südmeyer
authors.forename: L
authors.initials: L
authors.lastname: Wojtecki
authors.forename: A
authors.initials: A
authors.lastname: Schnitzler
mesh_terms: D000368:Aged; D000818:Animals; D018726:Anti-Dyskinesia Agents / Q000627:therapeutic use; D000978:Antiparkinson Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D001058:Apomorphine / Q000008:administration & dosage / Q000627:therapeutic use; D003422:Critical Care; D046690:Deep Brain Stimulation; D003704:Dementia / Q000209:etiology / Q000628:therapy; D003863:Depression / Q000188:drug therapy / Q000209:etiology; D007174:Disruptive, Impulse Control, and Conduct Disorders / Q000209:etiology / Q000628:therapy; D018491:Dopamine Agonists / Q000009:adverse effects / Q000627:therapeutic use; D005060:Europe / Q000453:epidemiology; D005260:Female; D006801:Humans; D015918:Infusion Pumps, Implantable; D007980:Levodopa / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D009069:Movement Disorders / Q000209:etiology / Q000628:therapy; D010300:Parkinson Disease / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy / Q000453:epidemiology / Q000628:therapy*; D011618:Psychotic Disorders / Q000209:etiology / Q000628:therapy; D012893:Sleep Wake Disorders / Q000209:etiology / Q000628:therapy; D014202:Tremor / Q000188:drug therapy / Q000209:etiology
chemical_list: D018726:Anti-Dyskinesia Agents; D000978:Antiparkinson Agents; D018491:Dopamine Agonists; D007980:Levodopa; D001058:Apomorphine